Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Medinotec (MDNC) Capital Expenditures (2022 - 2025)

Medinotec's Capital Expenditures history spans 4 years, with the latest figure at -$179372.0 for Q1 2025.

  • For Q1 2025, Capital Expenditures fell 12675.78% year-over-year to -$179372.0; the TTM value through Feb 2025 reached -$89013.0, down 220.34%, while the annual FY2025 figure was -$89013.0, 3847.36% down from the prior year.
  • Capital Expenditures reached -$179372.0 in Q1 2025 per MDNC's latest filing, down from $72626.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $86602.0 in Q4 2022 to a low of -$179372.0 in Q1 2025.
  • Average Capital Expenditures over 4 years is -$12569.6, with a median of -$3910.0 recorded in 2023.
  • Peak YoY movement for Capital Expenditures: skyrocketed 98.05% in 2023, then tumbled 12675.78% in 2025.
  • A 4-year view of Capital Expenditures shows it stood at $86602.0 in 2022, then plummeted by 102.04% to -$1765.0 in 2023, then soared by 4214.79% to $72626.0 in 2024, then tumbled by 346.98% to -$179372.0 in 2025.
  • Per Business Quant, the three most recent readings for MDNC's Capital Expenditures are -$179372.0 (Q1 2025), $72626.0 (Q4 2024), and $23788.0 (Q3 2024).